Antiangiogenesis Mediates Cisplatin-Induced Peripheral Neuropathy

Abstract

These findings implicate microvascular damage as the basis for toxic neuropathy induced by cisplatin and suggest that local angiogenic gene therapy may constitute a novel prevention or treatment for this disorder without augmenting tumor growth or vascularization.